WKN: | A1JX3U |
ISIN: | US8684591089 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Supernus Pharmaceuticals,-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 15. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2016 | 12,23 | 24,00 | 96,24% |
2 | 2015 | 6,85 | 12,23 | 78,54% |
3 | 2017 | 24,00 | 34,29 | 42,88% |
4 | 2024 | 26,40 | 35,60 | 34,85% |
5 | 2021 | 20,20 | 26,40 | 30,69% |
6 | 2022 | 26,40 | 33,40 | 26,52% |
7 | 2014 | 5,76 | 6,85 | 18,92% |
8 | 2025 | 35,60 | 39,60 | 11,24% |
9 | 2020 | 20,80 | 20,20 | -2,88% |
10 | 2018 | 34,29 | 28,35 | -17,32% |
11 | 2023 | 33,40 | 26,40 | -20,96% |
12 | 2019 | 28,35 | 20,80 | -26,63% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2019 | 28,35 | 20,80 | -26,63% |
2 | 2023 | 33,40 | 26,40 | -20,96% |
3 | 2018 | 34,29 | 28,35 | -17,32% |
4 | 2020 | 20,80 | 20,20 | -2,88% |
5 | 2025 | 35,60 | 39,60 | 11,24% |
6 | 2014 | 5,76 | 6,85 | 18,92% |
7 | 2022 | 26,40 | 33,40 | 26,52% |
8 | 2021 | 20,20 | 26,40 | 30,69% |
9 | 2024 | 26,40 | 35,60 | 34,85% |
10 | 2017 | 24,00 | 34,29 | 42,88% |
11 | 2015 | 6,85 | 12,23 | 78,54% |
12 | 2016 | 12,23 | 24,00 | 96,24% |